Fashion Week Re‑embraces the 1990s „Heroin Chic” Look Thanks to GLP‑1 Drugs

GLP‑1s and the New Body Ideal

The trend has resurfaced at Paris, Milan, London and New York Fashion Weeks, where models with extreme leanness and cigarette‑holding poses dominate runways. The revival began in early 2026, after the widespread adoption of GLP‑1 medications for weight loss, which enable users to achieve drastic reductions in body mass. Fashion houses have seized the opportunity to showcase the new „thin” aesthetic, citing the drugs’ popularity among celebrities and influencers.

The resurgence is driven by a combination of medical innovation and cultural nostalgia. GLP‑1s, originally designed to treat type‑2 diabetes, have become a mainstream weight‑loss solution. Their ability to suppress appetite and promote rapid fat loss has produced a new cohort of very slim individuals. Designers, eager to tap into the „authentic” look that the 1990s drug‑culture aesthetic promised, have embraced these models. Runway shows now feature elongated silhouettes, pale skin, and cigarette‑holding poses reminiscent of the era’s underground fashion scene.

GLP‑1 medications, such as semaglutide and tirzepatide, have been prescribed to millions worldwide. Clinical trials report average weight losses of 15–20% of body weight within 12 weeks. The rapid transformation has led many users to adopt the „heroin chic” look, characterized by extreme thinness, a pale complexion, and a casual smoking pose. Fashion editors note that the aesthetic feels „authentic” because it mirrors the real‑world effects of these drugs.

Is the Trend a Sign of a Health Crisis?

The trend has sparked debate among health professionals. Dr. Elena Marquez, an endocrinologist, warns that the drugs can cause serious side effects, including pancreatitis and gallbladder disease. „While the aesthetic may be striking, the health risks are significant,” she says. Yet, the allure of a dramatic body transformation continues to drive demand, and the fashion industry has capitalized on it.

The revival of the „heroin chic” look raises questions about the relationship between fashion and public health. Critics argue that the trend normalizes extreme thinness and smoking, potentially influencing vulnerable audiences. Social media influencers who have lost weight on GLP‑1s often post images of themselves smoking, further blurring the line between health and harm.

Fashion houses have responded by issuing statements that they are „celebrating body diversity.” However, the actual runway shows still showcase models who appear to be in the early stages of GLP‑1 therapy, with visible weight loss and a cigarette in hand. The question remains whether the industry is responsible for promoting a potentially dangerous body image.

The trend may have lasting effects on both the fashion world and public perception of health. If the aesthetic persists, it could reinforce the idea that extreme leanness is desirable, even when achieved through pharmaceutical means. Meanwhile, medical professionals will likely increase scrutiny of GLP‑1 prescriptions, especially among young adults who may be influenced by runway imagery.

Frequently Asked Questions

What are GLP‑1 drugs and how do they affect weight? GLP‑1 drugs are injectable medications that mimic a hormone involved in appetite regulation. They can reduce hunger and increase satiety, leading to significant weight loss in a short period.

Is smoking portrayed in the new fashion trend safe? No. Smoking remains a major health risk, causing cancer, heart disease, and respiratory problems. The trend does not mitigate these dangers.

Will the „heroin chic” aesthetic continue beyond 2026? It is uncertain. While the current trend is fueled by GLP‑1 popularity, shifting cultural attitudes and health regulations could alter its trajectory.